| Study | Treatment 1 | Treatment 2 | RR | 95% CI lower limit | 95% CI upper limit |
| Cavigelli‐Brunner 2018 | Dobutamine | Milrinone | 0.5275 | 0.1763 | 1.5784 |
| Costello 2014 | Milrinone | Placebo | 1.7554 | 1.0976 | 2.8076 |
| Hoffman 2003 | Milrinone | Milrinone LD | 1.1766 | 0.4440 | 3.1180 |
| Hoffman 2003 | Milrinone LD | Placebo | 1.4920 | 0.5257 | 4.2341 |
| Hoffman 2003 | Milrinone | Placebo | 1.7554 | 1.0976 | 2.8076 |
| Pellicer 2013 | Levosimendan | Milrinone | 0.6812 | 0.2675 | 1.7346 |
| Thorlacius 2020 | Levosimendan | Milrinone | 0.6812 | 0.2675 | 1.7346 |
| Wang 2019 | Levosimendan | Placebo | 1.1959 | 0.4577 | 3.1245 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.